Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

If that's true would you not expect the press releases in both cases to clarify that the agreements include future product for sale language in addition to the "clinical" material that they appear to be focused on?

No, I’ve rarely seen future sale language in PRs. GMP-like lab production can be in place until the start of Phase 3, but most use cGMP before phase 2. These things are never PRed that I know of. What IPIX is doing is creating a “turn-key” supply line that an acquiring pharma can then do what it wants to do, including ramp up its own manufacturing source having more resources at its disposal to develop its own supply lines. The important thing is to demonstrate the ability to bulk produce product that is market ready no matter the licensee or acquirer.

Meanwhile the releases don't make it clear that these manufacturers will be doing that manufacturing.

Correct, see above.